Amgen Sues Actavis, Indian Cos. Over Sensipar Generics
Amgen Inc. accused Actavis Inc.'s Watson Laboratories Inc. and two Indian drug companies in Delaware federal court of infringing a patent for its blockbuster calcium reducer Sensipar when asking the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article